Sertraline on Obsessive Compulsive Disorders in Indonesia (A Case Study)




Background: Obsessive-compulsive disorder (OCD) was originally believed to be a rare mental illness. However, recent surveys and research have shown that OCD is one of the most common mental disorders. Research in India showed that the treatment of OCD using SSRIs (selective serotonin reuptake inhibitors) is preferred over the tricyclic group. This paper will discuss sertraline as the alternative to clomipramine for OCD.

Objective: Clomipramine as the treatment of choice for OCD is no longer included in the Indonesian MIMS index. Recent research suggests sertraline is preferred over clomipramine, and this paper discusses the efficacy of sertraline through a case study.

Methods: This study is a retrospective descriptive study on the case of 21-year-old male met the ICD-X criteria of OCD for having unwanted thoughts and repetitive behavior for locking the door and orderly compiling the books. The symptoms developed since he graduated from high school (three years before admission) and got worse since the last year. Sertraline was prescribed in the first place. The patient was routinely monitored during each visit for the next three months.

Results: The symptoms improved significantly after routinely taking sertraline for two months. The adverse effects were well-tolerated, such as nausea, headaches, and tachycardia. Psychotherapy was needed to modify the patient’s obsession and to anticipate the risk of personality disorder should be noticed because the disorder appeared at a young age.

Conclusion: Sertraline as well as psychotherapy are worthy of consideration as first-line OCD therapy in Indonesia.


Download data is not yet available.

Author Biographies

Hafid Algristian , Department of Psychiatry, Faculty of Medicine, Nahdlatul Ulama University Surabaya

Research lecturer, Department of Psychiatry, Faculty of Medicine, Nahdlatul Ulama University Surabaya

Nur Azizah AS, Department of Psychiatry, Faculty of Medicine, Nahdlatul Ulama University Surabaya

Research lecturer, Department of Psychiatry, Faculty of Medicine, Nahdlatul Ulama University Surabaya


Al-Sharbati, Z., Al-Sharbati, M., Gupta, I., Al-Sharbati, Z., Al-Sharbati, M., & Gupta, I. 2014. Cognitive Behavioral Therapy for Obsessive Compulsive Disorder. Obsessive-Compulsive Disorder - The Old and the New Problems. DOI:

Boland, R., Verduin, M. L., & Ruiz, P. 2022. Obsessive Compulsive and Related Disorders. In Kaplan & Sadock’s Synopsis of Psychiatry Twelfth Edition. Wolters Kluwer.

Brock, H., & Hany, M. 2022. Obsessive-Compulsive Disorder. StatPearls.

Casale, A. Del, Sorice, S., Padovano, A., Simmaco, M., Ferracuti, S., Lamis, D. A., Rapinesi, C., Sani, G., Girardi, P., Kotzalidis, G. D., & Pompili, M. 2019. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD). Current Neuropharmacology, 17(8): 710. DOI:

Edinoff, A. N., Akuly, H. A., Hanna, T. A., Ochoa, C. O., Patti, S. J., Ghaffar, Y. A., Kaye, A. D., Viswanath, O., Urits, I., Boyer, A. G., Cornett, E. M., & Kaye, A. M. 2021. Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review. Neurology International, 13(3): 387. DOI:

Elvira, S., & Hadisukanto, G. 2018. Buku Ajar PSKIATRI Edisi Ketiga (Noorhana, Ed.; 3rd ed.). Badan Penerbit Fakultas Kedokteran Universitas Indonesia.

Fineberg, N. A., Brown, A., Reghunandanan, S., & Pampaloni, I. (2012). Evidence-based pharmacotherapy of obsessive-compulsive disorder. International Journal of Neuropsychopharmacology 15(8): 1173–1191. DOI:

Geller, D. A., Homayoun, S., & Johnson, G. 2021. Developmental Considerations in Obsessive Compulsive Disorder: Comparing Pediatric and Adult-Onset Cases. Frontiers in Psychiatry 12: 1–15. DOI:

Goodman, W. K., Grice, D. E., Lapidus, K. A. B., & Coffey, B. J. 2014. Obsessive-compulsive disorder. Psychiatric Clinics of North America, 37(3): 257–267. DOI:

Grover, S., Avasthi, A., & Jagiwala, M. (2020). Clinical Practice Guidelines for Practice of Supportive Psychotherapy. Indian Journal of Psychiatry, 62(Suppl 2), S173. DOI:

Jones, P. J., Mair, P., Riemann, B. C., Mugno, B. L., & McNally, R. J. (2018). A network perspective on comorbid depression in adolescents with obsessive-compulsive disorder. Journal of Anxiety Disorders 53: 1–8. DOI:

Klenfeldt, I. F., Karlsson, B., Sigström, R., Bäckman, K., Waern, M., Östling, S., Gustafson, D., & Skoog, I. 2014. Prevalence of obsessive-compulsive disorder in relation to depression and cognition in an elderly population. American Journal of Geriatric Psychiatry 22(3): 301–308. DOI:

Markowitz, J. C. 2014. What is Supportive Psychotherapy? Https://Doi.Org/10.1176/Appi.Focus.12.3.285 20(12): 1–3. DOI:

Maslim, R. 2013. F42 Gangguan Obsesif Kompulsif. In Dignosis Gangguan Jiwa Rujukan Ringkas dari PPDGJ-III dan DSM-5 (pp. 76–77).

Moraczewski, J., & Aedma, K. K. 2022. Tricyclic Antidepressants. Veterinary Psychopharmacology, 231–256.

Moulding, R., Hughes, M. E., Byrne, L., Do, M., & Nedeljkovic, M. 2016. Obsessive compulsive disorder. Developmental Disorders of the Brain: Second Edition 5(1): 173–190. DOI:

Nezgovorova, V., Reid, J., Fineberg, N. A., & Hollander, E. 2022. Optimizing first line treatments for adults with OCD. Comprehensive Psychiatry, 115(March), 152305. DOI:

Pascual, R. D., Evaria, Grace, A., Carmela, & Mari, P. 2022. Antidepresan. In S. Ismael, M. Almatsier, R. Setiabudy, R. Firmansyah, A. Sani, & Handaya (Eds.), MIMS PETUNJUK KONSULTASI EDISI 21 2021/2022 INDONESIA (21st ed., pp. 47–49). Bhuana Ilmu Populer (Kelompok Gramedia).

Perez, A. 2021. SSRIs (Selective Serotonin Reuptake Inhibitors): What Are They? Healthline.

Pittenger, C. 2017. Obsessive-compulsive Disorder: Phenomenology, Pathophysiology, and Treatment (Issue August). Oxford University Press. DOI:

Pittenger, C., & Bloch, M. H. 2014. Pharmacological treatment of obsessive-compulsive disorder. Psychiatric Clinics of North America 37(3): 375–391. DOI:

Reddy, J. Y. C., Sundar, A., Narayanaswamy, J., & Math, S. 2017. Clinical practice guidelines for Obsessive-Compulsive Disorder. Indian Journal of Psychiatry, 59(Suppl 1), S74. DOI:

Rizal, R. R., & Fiana, D. N. 2021. Serotonin Syndrome : Mekanisme dan Pemicu. Dewi Nur Fiana | Serotonin Syndrome Medula |, 11(1), 196–204.

Sassano-Higgins, S. A., & Pato, M. T. 2015. Obsessive-Compulsive Disorder: Diagnosis, Epidemiology, Etiology, and Treatment. Focus 13(2): 129–141. DOI:

Soomro, G. M. 2012. Obsessive compulsive disorder. BMJ Clinical Evidence, 2012.

Stein, D. J., Costa, D. L. C., Lochner, C., Miguel, E. C., Reddy, Y. C. J., Shavitt, R. G., van den Heuvel, O. A., & Simpson, H. B. 2019. Obsessive–compulsive disorder. Nature Reviews. Disease Primers 5(1): 52. DOI:

Syamsuddin, S., Syauki, A. S., Ismail, M. W., & Nadya, A. N. 2022. Buku Ajar Psikiatri Gangguan Ansietas Fobik dan lainnya, Obsesif Kompulsif, Reaksi Terhadap Stres, Disosiatif, Dan Somatoform (M. A. Jaya, Ed.). PT. Nas Media Indonesia.

Vildayanti, H., Puspitasari, I. M., & Sinuraya, R. K. 2018. Review: Farmakoterapi Gangguan Anxietas. Farmaka 16(1): 196–213.

Wilson, M., & Tripp, J. 2022. Clomipramine. XPharm: The Comprehensive Pharmacology Reference, 1–5.

Yahya, & Megalia, M. 2017. Pengaruh Konseling Cognitif Behavior Therapy (CBT) dengan Teknik Self Control untuk Mengurangi Perilaku Agresif Peserta Didik Kelas VIII di SMPN 9 Bandar Lampung Tahun Pelajaran 2016/2017. KONSELI : Jurnal Bimbingan Dan Konseling (E-Journal), 3(2): 133–146. DOI:




How to Cite

Faisal, M. R., Algristian , H., & Azizah AS, N. (2023). Sertraline on Obsessive Compulsive Disorders in Indonesia (A Case Study) . International Islamic Medical Journal, 4(1), 5–11.